# Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) Patients

> **NCT00081783** · PHASE2 · UNKNOWN · sponsor: **Xcyte Therapies** · enrollment: 40 (—)

## Conditions studied

- Non-Hodgkin's Lymphoma

## Interventions

- **DRUG:** Xcellerated T Cells

## Key facts

- **NCT ID:** NCT00081783
- **Lead sponsor:** Xcyte Therapies
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 40 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00081783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00081783, "Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00081783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*